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Abstract
Background: Australia’s Indigenous people suffer from higher cancer mortality than
non-Indigenous Australians, a discrepancy partly caused by differences in beliefs about
treatment efficacy between Indigenous patients and their non-Indigenous healthcare
providers. This paper critically reviews the literature associated with Indigenous beliefs
about cancer treatment, both ‘bush medicine’ and biomedical, in order to provide
recommendations to healthcare providers about accommodating Indigenous beliefs
when treating cancer.
Methods: A search was undertaken of peer-reviewed journal papers using electronic
databases and citation snowballing. Papers were selected for inclusion based upon
relevance to themes that addressed the research questions.
Results: Literature suggests that Indigenous beliefs about treatment efficacy for cancer
involve five themes: (i) concerns about the toxicity of treatment; (ii) disconnect with the
physician; (iii) fears about absence from home during treatment; (iv) different beliefs
about disease aetiology; (v) biomedical cancer treatments failing to address holistic
health.
Conclusions: Although some information is known about Indigenous Australian
healing beliefs and practices associated with cancer treatment, few studies have
addressed ways in which Indigenous and biomedical approaches to cancer treatment
might be integrated. Some recent work has examined the role of belief in cancer
treatment, specifically bush medicine, but more research is required.

Introduction
Indigenous Australians suffer from higher cancer morbidity and mortality than non-Indigenous Australians.1–3
They are less likely than non-Indigenous people to use
preventive and screening services, and, when diagnosed,
to receive treatments such as surgery, chemotherapy and
radiotherapy.4 There are many reasons for this discrepancy, including socioeconomic and educational factors,
language barriers, and lack of healthcare provider familiarity with cultural practices and transportation issues.5
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In the last decade, several studies have identified
another, less obvious reason for discrepancies in cancer
outcomes: differences of explanatory models of illness and
belief systems.6,7 Such research has revealed that in some
cases, Indigenous peoples’ unwillingness to receive treatment for cancer is related to their beliefs about the disease
and its treatment: for example, that cancer is incurable,
that biomedical treatment is excessively toxic or that
biomedical treatment may not be effective if the cancer
occurred as a form of payback.8–10 Indigenous patients may
be more willing to receive biomedical treatment if their
healthcare providers paid greater attention to Indigenous
beliefs about cancer. A healthcare provider’s willingness to
incorporate elements of Indigenous treatments and
explanatory models into a treatment plan has led to better
outcomes for Indigenous cancer patients.6,7
This paper reviews the literature available on Indigenous beliefs in treatment efficacy to distil what can be
learned from these combined sources, with the goal of
© 2011 The Authors
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guiding healthcare providers’ consideration of beliefs
about treatment in developing cancer treatment plans for
Indigenous Australians. Furthermore, the review seeks to
identify gaps in knowledge and areas for future research.
Characterisation of explanatory models and belief
systems and application of such knowledge to medical
practice are essential to reducing morbidity and mortality
among Indigenous people with cancer.

Methods – search strategy
and approach
This review draws upon the existing literature to present
a summary of what is known about Indigenous views of
bush medicine and biomedical treatments for cancer, and
to provide recommendations for healthcare providers
about accommodating both treatment types with the
goal of reducing cancer mortality among Indigenous
Australians.
We undertook a search of the literature for material
relevant to the following research questions:
• What is known about Indigenous Australians’ views of
biomedical cancer treatment?
• What is known about Indigenous Australians’ views of
bush medicine treatments for cancer?
• What success, if any, has there been in combining
these two approaches to treat cancer in Indigenous Australian patients?
• What recommendations might be presented to Australian healthcare providers to facilitate their integration of
both treatment methods, with the goal of improving outcomes and decreasing morbidity and mortality among
Indigenous Australian cancer patients?
The search process was similar to a systematic review
in methodically utilising electronic databases, and it also
incorporated the critical interpretive synthesis approach
in that themes emerged as the literature was searched.
This dual method was more appropriate given the relative paucity of literature relevant to the topic at the time
of writing.
Peer reviewed journal papers were selected following a
search of electronic databases including Proquest, Science
Direct, Google Scholar, PubMed, Medline, Academic
Search Premier (EBSCO), PsychINFO, Informit and ISI
Web of Knowledge, and citation snowballing was undertaken. Key search terms used included combinations of
the following: Indigenous, Aboriginal, cancer, belief,
bush medicine, treatment. Publications were considered
for inclusion if they addressed at least one of the research
questions mentioned earlier. Papers that did not refer to
Indigenous or Aboriginal or Torres Strait Islander people
of Australia were excluded.
© 2011 The Authors
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Results
Available literature revealed five themes related to Indigenous people’s beliefs about treatments and treatment
efficacy for cancer:
1 Concerns about the toxicity, side-effects and potential
disfigurement of treatment.
2 A feeling of disconnect with the physician.
3 Fears about distance from home and family when
treatment requires relocation to a hospital far from
home.
4 Beliefs about disease aetiology that differ from those
presented by the Western biomedical model.
5 Failure of biomedical treatments to address holistic
health, in contrast to bush medicine treatments that do
address holistic health.

Concerns about the toxicity, side-effects and
potential disﬁgurement from treatment
The outcomes of many qualitative studies reveal Indigenous concerns about the toxicity, side-effects, and
potential disfigurement of cancer treatment, and these
beliefs underpin to some extent quantitative hospital
admission data showing that Indigenous people are less
likely to receive aggressive cancer therapies. Condon et al.
completed a retrospective cohort study of 1197 Indigenous and non-Indigenous people in the Northern Territory diagnosed with colon, rectum, lung and breast
cancer, as well as with non-Hodgkin lymphoma, between
1991 and 2000.4 Surgery was recommended for 70% of
non-Indigenous patients and 61% of Indigenous
patients; chemotherapy for 34 and 35%, and radiotherapy for 34 and 36% of non-Indigenous and Indigenous patients respectively. Of the patients for whom
each procedure was recommended, for non-Indigenous
and Indigenous patients, respectively, 99% and 90%
chose surgery, 93 and 87% chose chemotherapy, and 94
and 84% chose radiotherapy. Finally, of the patients who
chose the procedures, for non-Indigenous and Indigenous patients, respectively, 99 and 100% completed
surgery, 83 and 68% completed chemotherapy, and 96
and 88% completed radiotherapy. This demonstrates
a difference in treatment for Indigenous people, in
providers’ treatment recommendations, and in patients’
consent to and completion of treatment.4
Qualitative studies have attempted to characterise the
reasons for these discrepancies. Prior indicates that
interviews, focus groups, and community observation in
a remote community in Queensland revealed ‘a prevailing belief among Indigenous women that cancer was a
“deadly disease” and that treatment was mostly futile’.8
Moreover, women ‘dreaded the prospect of cancer
185
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treatment especially if it involved surgery’.8 Mastectomies were especially anxiety-provoking for Indigenous
women ‘because the breast was a vital part of their
“womaness” and could threaten relationships with their
husbands or partners’.8 McMichael records that some
women felt that loss of a breast signified an inability to
provide life and nutrition for children, an essential
aspect of womanhood.9 The paper by Satherley featuring the work of Michelle Torrens, an Indigenous
ovarian cancer survivor who wrote a book about her
experiences, suggests that fear of loss of hair, another
important symbol of womanhood, is also a treatment
deterrent: ‘When they mentioned giving me chemotherapy,. . . I seriously considered not having it and just
going home. To me, like to most of my friends, the
word has very scary connotations. You think you are
going to get even sicker and that all of your hair will
fall out and never grow back. For us Indigenous
women, our beauty is our hair. It is almost sacred and
I didn’t want to lose it’.11
In addition to the loss of physical symbols of womanhood and one’s place within the community, the nausea
and sickness associated with chemotherapy were concerning for Indigenous patients. McMichael quotes a
woman who reported that her ‘aunt had chemotherapy
for breast cancer, but I don’t know how well it treated it.
She had it a couple of times but then stopped it. It made
her sick. She didn’t feel that it was doing her any good’.9
McMichael’s work showed that among women with
breast cancer, pre-existing belief in efficacy can be diminished by the negative side-effects of the biomedical treatment, which ‘does not fit with the women’s view of
health as feeling well and being able to care for one’s
children (or grandchildren)’.9
Shahid, interviewing Indigenous cancer survivors,
cancer patients and close relatives of cancer patients,
found that some patients used traditional healers and
bush medicine, in part to help cope with the toxicity of
radiation and chemotherapy. One respondent described
an acquaintance who had forsaken biomedical treatments for bush medicine: ‘She looked better when she
took the bush medicine’.7 Some Indigenous respondents
said they would be willing to try bush medicine if
Western medicine failed, and others reported using bush
medicine concurrently with chemotherapy when available, often without telling their doctors because the providers never inquired about bush medicine use.7

A feeling of disconnect with the physician
Patient-physician relationships can be prone to miscommunication regardless of the patient’s cultural
background, and such miscommunication is especially
186

an issue for Indigenous patients: there is no Indigenous
word for cancer.10,12 Physician communication and
patient understanding of treatments – their side-effects,
duration and recovery time – is often difficult to achieve
for both linguistic and cultural reasons.13 The general
dangers of miscommunication in healthcare settings,
described in the following, are especially applicable to
Indigenous cancer patients: ‘taking prescribed drugs
without a full knowledge of their purpose or side-effects,
being admitted to hospital unaware of the type of medical
treatment the patient was to receive, receiving medical
treatment without consent, being mistaken for other hospital patients and receiving inappropriate treatment,
being returned home with a serious condition, patients
undergoing treatment at odds with [patients’] cultural
beliefs’.13 These consequences of miscommunication are
profound for cancer patients, who often have complicated treatment plans and are immunocompromised.
There are many anecdotes of the dangers of
physician-patient miscommunication with Indigenous
cancer patients, some of which have been published:14
one patient with throat cancer had his larynx removed,
unaware that his tracheostomy and gastrostomy tubes
would be permanent and would require cleaning. His
wife thought that the operation would cure him, and
his inability or unwillingness to clean the tubes led to
his rehospitalisation, a few weeks after which he passed
away. The paper containing this story provides similar
descriptions of cultural collision and misunderstanding
with potentially avoidable consequences, had treatment
been explained more fully to the patients.14
Such miscommunication between Indigenous patients
and their physicians compounds a pre-existing lack of
trust in the Western medical establishment.15 An assessment of patients who chose to take their own leave from
hospital in Alice Springs revealed that one individual
attributed leaving to having seen a nurse hit a child.16
Further questioning indicated that the incident had happened years prior, but that the event remained in the
patient’s mind, reinforcing collective cultural memory:
such concerns continue to influence Indigenous attitudes
towards the hospital in a negative way, discouraging participation in treatment.
Related to miscommunication and lack of trust in the
Western medical establishment is the issue of ‘unrealistic
expectations’ of cancer treatment.9,10,12 The lack of effective communication can lead patients to believe that
cancer treatments will necessarily lead to a cure. If such
an outcome does not result, the potential exists for
further distrust of the Western medical establishment
and biomedical treatments by Indigenous community
members, who often see patients leave their communities for treatment only to die while in hospital.9
© 2011 The Authors
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Fears about distance from home and family
when treatment requires relocation to a
hospital far from home
Although the concern of Indigenous patients that treatment for cancer requires travel and being distant from
home and family is not directly related to views of treatment efficacy, such views remain important reasons for
foregoing biomedical treatment, and therefore merit discussion here.
Cancer treatment usually occurs at larger medical
centres that may be hundreds of kilometres away from
where a patient lives, in an environment that is culturally
distant from home.5,8,9,14,15 Cancer diagnosis and treatment
are stressful times,9 and the stress is worsened by the lack
of a social support network when the patient is in hospital
for treatment, and by considerations of logistics and
costs.17 Moreover, travelling to hospital and remaining
there for treatment means that patients cannot fulfil community social obligations,8,9 prompting some patients to
decline any hospital-based treatment so they can remain
at home.8 Many patients taking their own leave from Alice
Springs Hospital, for example did so because of distance
from home and family.16 Additionally, cancer itself can be
isolating, as some Indigenous patients and their families
believe that cancer is contagious and will shun contact
with the affected person:6,8,9,12 the feeling of emotional
distance and isolation from one’s community, which
might follow a cancer diagnosis, can be compounded by
the physical distance imposed by having to receive treatment at hospitals away from home and family.

Beliefs about disease aetiology that differ
from those presented by the Western
biomedical model
Among some Indigenous people there is a perception that
cancer is a ‘white man’s disease’, brought to the continent by Europeans, and that it therefore requires ‘white
man’s medicine’ and is especially toxic to Indigenous
people.8,10 This perception of cancer as a European
malady links it to other diseases brought to the continent
by the first European settlers, such as gonorrhoea and
syphilis – diseases that have a social stigma and induce
feelings of shame in those who contract them.7 Moreover, cancer can be considered to have been brought on
by sorcery as a form of payback,6,7,12 and Indigenous
patients with cancer can experience shame in the face of
a cancer diagnosis.6–8
These perceptions of cancer aetiology affect Indigenous
peoples’ perceptions of how cancer should be treated.
While living in a Warlpiri community, Saethre investigated perceptions of disease and treatment, focusing on
© 2011 The Authors
Internal Medicine Journal © 2011 Royal Australasian College of Physicians

the types of treatment sought for particular illnesses.18
Although the patient stories provided do not include the
experiences of cancer, the data are useful in that they
show a tendency to seek Western medications such as
paracetamol and antibiotics when they are available.
Bush medicine was used but could often be difficult to
obtain.18,19 Urban Indigenous respondents have also indicated that though they might like to use bush medicine,
they cannot owing to an inability to procure it in the
urban environment.7 This suggests that although
Western medicines might be considered useful for illnesses perceived to be ‘white man’s diseases’, traditional
healers are still sought: this is particularly the case if the
reason for the disease is believed to be a form of payback.
Some believe that cancer affects only Indigenous
people,10 and one respondent in Saethre’s study indicated
that a disease that affects only Indigenous people needed
to be cured by a traditional healer: ‘Those doctors, they
don’t understand Indigenous sickness. They do X-rays
but they still can’t see that bone inside’.18
The literature reveals different and sometimes conflicting views about the effects of cancer on Indigenous
patients, though a common theme is the view that cancer
did not exist prior to the arrival of European settlers, and
that its status as a disease brought by Europeans affects
how it should be treated by healers, both traditional and
biomedical. Regardless, it is clear that colonial history has
shaped perceptions of disease aetiology and treatment
efficacy, both biomedical and Indigenous, for specific diseases in Indigenous patients.

Failure of biomedical treatments to address
holistic health, in contrast to bush medicine
treatments that do address holistic health
As discussed in the work of Boulton-Lewis, which
describes beliefs of Indigenous health sciences students,
health is defined as ‘wellbeing’, affected by lifestyle
choices and relationships, and ‘involves balanced holistic
dimensions, including ‘physical, mental, spiritual and in
some cases social and environmental aspects’.20 Illness
was perceived as ‘imbalance involving holistic dimensions including physical, spiritual, social and environmental’. Some students responded that illness could be
induced by interaction with evil or unhappy spirits. In
contrast, the Western perception of illness, particularly
cancer, is one of ‘biomedical reductionism’.10,21 Miscommunication about the process of cancer treatment and
unwillingness or inability to adhere to treatment programmes can often be traced back to these two very
different views of health, illness, and treatment.
Some Indigenous cancer patients consider biomedical
treatment inadequate, especially because (as described
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earlier) side-effects make them feel worse than they
did prior to treatment. Bush medicine is perceived as
addressing holistic health, ‘often signifying a reconnection to land, ancestral and spiritual roots that
enhanced the person’s overall wellbeing’.6 As one
respondent said about bush medicine: ‘There is something in it . . . that is good for your insides, just as a
cleanser. Makes all your body organs healthy and strong,
it gets rid of all your internal stress’.6 The view of bush
medicine as a stress reliever fits with a view of cancer as
stress-related, an effect of the upheavals and social
changes associated with European colonisation.7 Bush
medicine is believed to relieve stress and to act as a cancer
therapy that simultaneously prevents, treats and palliates
(for terminal patients).7
In some cases, Indigenous patients seek Western
medical care and the skills of a traditional healer, or
understand the scientific aetiology of a disease in the
context of traditional Indigenous belief systems.18 This
allows for the combination of viewpoints, treatments and
perspectives but often occurs in an uncoordinated way,
with inadequate treatment for Indigenous patients and
frustration for healthcare providers. A more effective and
efficient way to treat Indigenous patients is to recognise
at the outset the importance of holistic healing and to
incorporate it into the treatment programme. This is discussed in further detail below.

Success in combining
treatment approaches?
Literature detailing methods for combining biomedical
and traditional healers or biomedical and bush medicine
treatment is nearly non-existent. There is evidence that
Indigenous cancer patients and survivors, as well as the
family members of individuals with cancer, are willing to
use both treatment approaches.6,7
Saethre provides a first-hand anthropological account
of two Indigenous people in a Warlpiri community who
sought both biomedical and bush medical treatments for
their illnesses.18 Saethre makes the distinction between
physical illnesses and spiritual illnesses, the former of
which can be treated with Western medicines or bush
medicines, the latter of which, sometimes caused by
sorcery, require the assistance of an ngangkari healer.
Both approaches may be pursued concurrently when an
illness – such as cancer – is presented to a Western physician while also believed to be caused by sorcery.8,10,22
Saethre discusses the practice of ‘two way’ medicine in
which ‘illness management continues to occur in the
clinic, but patients . . . have the choice of consulting
nurses, Indigenous Health Workers, or Indigenous
healers and being prescribed pharmaceuticals or bush
188

medicines’. Through describing the medical histories of
two community members, Saethre illustrates how Indigenous people adapt the two systems to suit their needs,
such as using biomedical drugs (antibiotics and paracetamol) concurrently with ngangkari consultation, or attributing severe illnesses treated in Western hospitals to
spiritual causes. Ultimately, Saethre reports how the ‘two
way’ system fails to recognise that this overlap occurs and
argues that ‘while local conceptions of health do influence how illness is conceived and treated, they should
not be automatically reduced to a single or rigid Indigenous system that is contrasted with biomedicine’.18
Since many Indigenous people are willing to seek biomedical treatment, an approach that seeks to separate
‘bush medicine’ and ‘biomedicine’ with regard to patient
care is likely to be ineffective for many Indigenous
people.4,6,17,19,20 Rather, effective treatment needs to integrate both approaches, and to recognise that Indigenous
patients can and do combine their perceptions of and
treatments for illnesses, including cancer.

Conclusion
The available research regarding Indigenous Australians’
beliefs about treatment efficacy for cancer reveals that
concerns about biomedical treatment side-effects, longdistance travel to hospitals, cultural distance between
patient and provider, differences in belief about disease
aetiology, and the inadequacies of biomedical treatment
with regard to holistic healing influence Indigenous
cancer patients’ willingness to undertake and to complete
biomedical therapy for cancer. The literature suggests
that Indigenous cancer patients generally view biomedical treatment as effective in treating cancer, a ‘white
man’s disease’ for which ‘white man’s medicine’ can be
effective.8,10 However, it is often difficult to identify the
extent to which Indigenous patients are truly ‘informed’
about biomedical cancer treatment, its side-effects, and its
efficacy, as evidenced by well-described problems with
communication between health providers and Indigenous patients,6,14,23 the actions of patients who begin
treatment and then cease because of side-effects and toxicity, as well as by the perception among some that treatment is tantamount to a cure.12
Few data have been collected about beliefs in efficacy
of bush medicine when used specifically for cancer,
though the work of Shahid suggests that belief in efficacy
is important.7 Only limited conclusions can be drawn
about the use of bush medicine for cancer, as little
research has been completed in this area. Indigenous
patients are also generally not forthcoming in sharing
information about bush medicine, possibly fearing that
their non-Indigenous providers will discourage them
© 2011 The Authors
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from taking it or otherwise induce feelings of shame.6,7
Moreover, research suggests that patients might be concerned that sharing information about bush medicine
will reduce its efficacy.6,7 It appears even more difficult to
explore the perspectives of traditional healers, given their
concerns of being custodians of traditional knowledge
that could be exploited by non-Indigenous people.6,7
This review of beliefs about treatment efficacy reveals
that more research is needed regarding Indigenous
expectations about side-effects and treatment toxicity
and the difficulties associated with patient-physician
communication. More research in these areas might contribute to Indigenous patients being encouraged to participate in cancer screening where the consequences of
finding an abnormality must be a consideration. Reducing the fear and mystery associated with treatment
means that if cancer were discovered, patients may be
more willing to complete a full treatment programme. A
thorough understanding of beliefs and anxieties about
treatment would allow healthcare workers to address
these concerns early, facilitating the promotion of participation in screening programmes. Australia could also
learn from other developed countries such as Canada,
New Zealand and the United States in their Indigenousled approaches that have been adopted in order to
improve treatment engagement and outcomes.24–27
Indigenous Australians are diverse and heterogeneous,
so treatment needs to be personalised to individual beliefs
and concerns. However, health providers showing that
they care enough to know about the beliefs of Indigenous
people that fall outside of the standard Western model
may also help Indigenous patients to feel that they are
receiving sincere, culturally sensitive care. The feeling of
‘being treated as a number’ and the absence of patientphysician relationship are recurring themes in research
exploring Indigenous peoples’ views of healthcare services.6 Identification of the broad range of thinking in
relation to healing, and specific beliefs about bush medicine – how it works, when it is used and what makes it
appealing – could promote among healthcare providers
greater willingness to use a more holistic healing model
when treating Indigenous patients. If beliefs about and
utilisation of bush medicine for cancer were more fully
characterised, treatment plans that combine both biomedical and bush medicine treatments could be developed, potentially leading to better psychosocial outcomes
as well as increased treatment adherence and patient
satisfaction, and decreased morbidity and mortality.
Moreover, as complementary medicine usage is so
common in the general community, changes in approach
– catalysed by the need to improve Indigenous cancer
outcomes – are likely to have broader applicability in the
multicultural societies of our modern world.
© 2011 The Authors
Internal Medicine Journal © 2011 Royal Australasian College of Physicians

Guidelines for healthcare providers
The following are some underlying guiding principles
for hospital Cancer Centres and those involved in
cancer care for Indigenous patients, provided from
the literature discussed, in order to promote more culturally safe and effective care for Indigenous cancer
patients.
• Indigenous involvement in the design and process of
care for Indigenous cancer patients is critical. Indigenous cancer patients often describe feelings of isolation
and cultural alienation, and the presence of another
Indigenous person, who has survived treatment, provides comfort and hope and facilitates patient-physician
communication. The presence of Indigenous health
workers or Indigenous hospital liaison officers, of the
same gender as the patient and who have survived
cancer themselves, was especially helpful during the
process of diagnosis and treatment.8,11 An Indigenous
health worker can play multiple roles in providing care
within the tertiary hospital environment and in forging
better linkages with primary and community-based
care.28–30 While design of cancer treatment facilities is
important, it has been argued that managing effective
treatment for Indigenous people within the current
medical system requires culturally sensitive person-toperson contact, support for Indigenous family structures
and a respect for the importance of place and community to Indigenous patients.31
• Healthcare providers should ensure, as much as possible, that cancer patients are truly informed prior to
commencing treatment. Informed consent consists of five
elements: competence, disclosure, understanding, voluntariness and consent.32 Attention to how communication
occurs and how information is given and received is
critical to understanding. The presence of an Indigenous
health professional or patient advocate will help facilitate
obtaining informed consent consistent with the definition earlier.
• Thought should be given to practical aspects of cancer
treatment, such as the difficulties of separation from
family, community and land; transportation to and
from the treatment site and associated expenses; and
ability to take time from work, whether domestic
(childcare) or occupational. Healthcare providers
should take these factors into account when developing
treatment plans to promote greater treatment adherence and overall patient wellbeing. The Indigenous
Women’s Cancer Support Group described by Finn and
colleagues shows the potential of Indigenous-led
support approaches.33
• Healthcare providers should make an effort to elicit
explanatory models for cancer and to learn about the
189
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belief system by which the Indigenous patient understands the world. If cancer is perceived as payback, and
the patient believes that the use of bush medicine or
Indigenous healing techniques is necessary, physicians
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Abstract
Background: There is a paucity of literature on the patterns and predictors of mortality
in idiopathic inflammatory myopathies (IIM).
Aims: To determine the patterns and predictors of mortality in a South Australian
cohort of patients with biopsy-proven IIM.
Methods: The living/deceased status (and for deceased patients the causes of death) of
patients with histologically determined IIM was determined from the Births, Deaths and
Marriages Registry. Standardised mortality ratios (SMR) were generated compared with
the age/gender matched South Australian population. The effect of presence/absence of
the components of the Bohan and Peter criteria on risk ratios (RR) for mortality
was determined. The effect of comorbidities and autoantibodies on mortality was
investigated.
Results: The SMR for mortality in IIM was 1.75 and was significantly increased in all
disease subgroups, being highest in patients with dermatomyositis (2.40). Dominant
causes of death were cardiovascular disease (31%), infections (22%) and malignancy
(11%). Risk factors for death were age at time of biopsy (hazard ratio 1.05), ischaemic
heart disease (RR 2.97, P < 0.0001), proximal weakness at diagnosis (RR 1.8, P = 0.03),
definite diagnosis of IIM per the Bohan and Peter criteria (RR 2.14, P < 0.0001), and the
absence of autoantibodies (RR 1.9, P < 0.001).
Conclusions: Patients with IIM are at 75% increased risk for mortality, and cardiovascular diseases account for the commonest causes of death. This study suggests a
thorough cardiovascular evaluation of these patients is indicated, and raises the possibility that targeted interventions such as the use of aspirin or statins may improve
outcomes in IIM.

Introduction
The idiopathic inflammatory myopathies (IIM) are a
group of systemic autoimmune diseases with dominant
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manifestations on skeletal muscle. The three best recognised disease subsets are polymyositis (PM), dermatomyositis (DM) and inclusion body myositis (IBM).1 As
for many autoimmune diseases, both genetic2 and
environmental3 factors are considered important, and
recently there has been considerable interest in the role
of myositis-specific and myositis-associated autoantibodies (MSA and MAA) in pathogenesis.4
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